Logo do repositório
 
Publicação

Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants

2025-01-06Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorBuchta, Christoph
dc.contributor.authorDe la Salle, Barbara
dc.contributor.authorMarrington, Rachel
dc.contributor.authorAburto Almonacid, Andrés
dc.contributor.authorAlbarède, Stéphanie
dc.contributor.authorBadrick, Tony
dc.contributor.authorBullock, David
dc.contributor.authorCobbaert, Christa M.
dc.contributor.authorCoucke, Wim
dc.contributor.authorDelatour, Vincent
dc.contributor.authorFaria, Ana Paula
dc.contributor.authorGeilenkeuser, Wolf-Jochen
dc.contributor.authorGriesmacher, Andrea
dc.contributor.authorHuggett, Jim F.
dc.contributor.authorIanovska, Viktoriia
dc.contributor.authorKammel, Martin
dc.contributor.authorKessler, Anja
dc.contributor.authorKörmöczi, Günther F.
dc.contributor.authorMeijer, Piet
dc.contributor.authorMiranda, Armandina
dc.contributor.authorPatel, Dina
dc.contributor.authorPezzati, Paola
dc.contributor.authorSandberg, Sverre
dc.contributor.authorSchennach, Harald
dc.contributor.authorSchweiger, Christian R.
dc.contributor.authorSchwenoha, Karin
dc.contributor.authorSpannagl, Michael
dc.contributor.authorSung, Heungsup
dc.contributor.authorThelen, Marc
dc.contributor.authorWeykamp, Cas
dc.contributor.authorZeichhardt, Heinz
dc.contributor.authorRestelli, Veronica
dc.contributor.authorPerrone, Lucy A.
dc.date.accessioned2026-02-20T14:50:50Z
dc.date.available2026-02-20T14:50:50Z
dc.date.issued2025-01-06
dc.description.abstractExternal quality assessment (EQA) enhances patient safety through the evaluation of the quality of laboratory-based and point of care testing. Regulatory agencies and accreditation organizations utilize the results and the laboratory's response to them as part of assessing the laboratory's fitness to practice. In addition, where EQA samples are commutable and the assigned value has been determined using reference measurement procedures (RMPs), EQA data contributes to the verification of metrological traceability of assays as part of the post-market surveillance of diagnostic (IVD) medical devices (IVD-MDs). More broadly, the scientific and medical communities use EQA data to demonstrate that medical laboratory examination procedures are fit for clinical purposes, to evaluate common reference intervals, and inclusion of data in clinical databases. Scientific groups, the IVD industry, reference laboratories and National Metrology Institutes can work with EQA providers to identify measurands, which should urgently be supported by the development of reference materials or methods. The ability of health systems to respond effectively to fast-evolving medical challenges, such as the Coronavirus Disease-19 (COVID-19) pandemic, is reliant on EQA to demonstrate confidence in the performance of new laboratory methods and testing services. EQA providers are uniquely positioned to assess the performance of IVD-MDs in addition to individual laboratories and testing sites. Although the primary focus of EQA providers remains the improvement of the performance of individual laboratories, there are many stakeholders who benefit from EQA performance data.
dc.identifier.citationClin Chem Lab Med. 2025 Jan 6;63(5):898-915. doi: 10.1515/cclm-2024-1293. Print 2025 Apr 28
dc.identifier.issn1434-6621
dc.identifier.pmid39753240
dc.identifier.urihttp://hdl.handle.net/10400.18/10968
dc.language.isoen
dc.peerreviewedyes
dc.publisherDe Gruyter
dc.relation.hasversionhttps://www.degruyterbrill.com/document/doi/10.1515/cclm-2024-1293/html
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectExternal Quality Assessment (EQA)
dc.subjectInterlaboratory Comparison
dc.subjectProficiency Testing (PT)
dc.subjectStakeholders
dc.subjectAvaliação Externa da Qualidade
dc.titleBehind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participantspor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage915
oaire.citation.issue5
oaire.citation.startPage898
oaire.citation.titleClinical Chemistry and Laboratory Medicine
oaire.citation.volume63
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
10.1515_cclm-2024-1293.pdf
Tamanho:
1.89 MB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

DEP - Artigos em revistas internacionais
INSA - Artigos em revistas internacionais